Also known as: Johns Hopkins
Insilico Medicine named ISM9528 as its 31st AI-driven preclinical pain candidate, published a target discovery study for a rare sinonasal cancer, and advanced partnerships with MSK and Takeda. The company is also presenting oncology programs at AACR 2026.
Systematic review confirms hepatitis B birth dose is safe and effective; separate study finds childhood vaccination linked to significantly lower HBV coinfection in people with HIV.
Wafik S. El-Deiry highlighted p53 research and the August 2025 approval of dordaviprone/modeyso, the first treatment for diffuse gliomas with H3K27M mutations. Separate posts also described glioblastoma precision oncology discussions and a lifetime achievement award in Mumbai.
ARVO named Sangeetha Kandoi and Ellen Konadu Antwi-Adjei as the 2026 recipients of its annual Advocacy Awards. The honors recognize advocacy in eye and vision research and efforts to expand equitable access to care.
Sen. Josh Hawley and Rep. Diana Harshbarger introduced legislation to withdraw FDA approval of mifepristone nationwide, making distribution a federal violation and allowing patients to sue manufacturers.
Ultrasensitive testing of tumor DNA in blood and urine may identify muscle-invasive bladder cancer patients who can safely forgo radical cystectomy, with 69% achieving 3-year bladder-intact survival after systemic therapy.
U.S. regulators have received more than 1,400 reports since 2021 involving AI-enabled surgical devices, including allegations of botched surgeries and misidentified body parts. The FDA has authorized over 1,300 AI-integrated medical devices.
Drug Hunter's monthly molecule selections from July through December 2025 feature innovative small molecule candidates targeting pain, epilepsy, cancer, infectious diseases, and metabolic disorders, including non-opioid pain agents and precision therapies for rare conditions.
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT07778823 |
Augmented Reality-Cardiopulmonary Resuscitation Support for Pediatric Resuscitation |
RECRUITING | NA |
| NCT07778810 |
Epidiolex Trial for Presymptomatic Treatment of Sturge-Weber Syndrome |
NOT_YET_RECRUITING | PHASE2 |
| NCT07772778 |
Evaluation of a Disability-Focused Sexual and Reproductive Health Curriculum for Health Students in Tanzania |
RECRUITING | PHASE3 |
| NCT07768267 |
Herbal Supplement (Biocidin REMOVE) for Bacterial Overgrowth in Irritable Bowel Syndrome |
NOT_YET_RECRUITING | PHASE2 |
| NCT07757555 |
Guanfacine and Cromolyn Sodium for POTS: The DBPOTS Trial |
NOT_YET_RECRUITING | EARLY_PHASE1 |
| NCT07744425 |
Shortwave Infrared Surgical Imaging Device Study |
ENROLLING_BY_INVITATION | |
| NCT07737535 |
Investigating Clinical Heterogeneity in Immune Checkpoint Inhibitor-induced Inflammatory Arthritis |
ACTIVE_NOT_RECRUITING | |
| NCT07734870 |
Tirzepatide for Treatment of CCCA |
NOT_YET_RECRUITING | PHASE2 |
| NCT07726173 |
Transventricular Off-pump Mitral Valve Repair |
RECRUITING | NA |
| NCT07725224 |
Use of a Smartphone App to Support Pre- and Post-Surgical Preparedness and to Improve Clinical Outcomes in Patients Undergoing Shoulder Arthroscopy |
NOT_YET_RECRUITING | NA |
